These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25079250)

  • 1. Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by a BKCa channel opener molecule.
    Hébert B; Pietropaolo S; Même S; Laudier B; Laugeray A; Doisne N; Quartier A; Lefeuvre S; Got L; Cahard D; Laumonnier F; Crusio WE; Pichon J; Menuet A; Perche O; Briault S
    Orphanet J Rare Dis; 2014 Aug; 9():124. PubMed ID: 25079250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndrome.
    Ferraguto C; Piquemal-Lagoueillat M; Lemaire V; Moreau MM; Trazzi S; Uguagliati B; Ciani E; Bertrand SS; Louette E; Bontempi B; Pietropaolo S
    Neuropsychopharmacology; 2024 Dec; 49(13):2032-2041. PubMed ID: 39223257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperacusis in the Adult
    Ferraguto C; Bouleau Y; Peineau T; Dulon D; Pietropaolo S
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Involvement of Impaired BK
    Carreno-Munoz MI; Martins F; Medrano MC; Aloisi E; Pietropaolo S; Dechaud C; Subashi E; Bony G; Ginger M; Moujahid A; Frick A; Leinekugel X
    Neuropsychopharmacology; 2018 Feb; 43(3):492-502. PubMed ID: 28722023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
    Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
    J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486.
    Dolan BM; Duron SG; Campbell DA; Vollrath B; Shankaranarayana Rao BS; Ko HY; Lin GG; Govindarajan A; Choi SY; Tonegawa S
    Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5671-6. PubMed ID: 23509247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome.
    Maurin T; Melancia F; Jarjat M; Castro L; Costa L; Delhaye S; Khayachi A; Castagnola S; Mota E; Di Giorgio A; Servadio M; Drozd M; Poupon G; Schiavi S; Sardone L; Azoulay S; Ciranna L; Martin S; Vincent P; Trezza V; Bardoni B
    Cereb Cortex; 2019 Jul; 29(8):3241-3252. PubMed ID: 30137253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
    Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voltage-Independent SK-Channel Dysfunction Causes Neuronal Hyperexcitability in the Hippocampus of
    Deng PY; Carlin D; Oh YM; Myrick LK; Warren ST; Cavalli V; Klyachko VA
    J Neurosci; 2019 Jan; 39(1):28-43. PubMed ID: 30389838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic reduction of MMP-9 in the Fmr1 KO mouse partially rescues prepulse inhibition of acoustic startle response.
    Kokash J; Alderson EM; Reinhard SM; Crawford CA; Binder DK; Ethell IM; Razak KA
    Brain Res; 2019 Sep; 1719():24-29. PubMed ID: 31128097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau reduction attenuates autism-like features in Fmr1 knockout mice.
    Zhao S; Jiang X; Han L; Jiang Y; Wang Y; Meng J; Zhu X; Zhang X; Luo H; Zhang YW
    Mol Autism; 2023 Nov; 14(1):42. PubMed ID: 37936174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of fragile X phenotypes by manipulation of AβPP/Aβ levels in Fmr1KO mice.
    Westmark CJ; Westmark PR; O'Riordan KJ; Ray BC; Hervey CM; Salamat MS; Abozeid SH; Stein KM; Stodola LA; Tranfaglia M; Burger C; Berry-Kravis EM; Malter JS
    PLoS One; 2011; 6(10):e26549. PubMed ID: 22046307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome.
    Zeier Z; Kumar A; Bodhinathan K; Feller JA; Foster TC; Bloom DC
    Gene Ther; 2009 Sep; 16(9):1122-9. PubMed ID: 19571888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Audiogenic Seizures in the
    Gonzalez D; Tomasek M; Hays S; Sridhar V; Ammanuel S; Chang CW; Pawlowski K; Huber KM; Gibson JR
    J Neurosci; 2019 Dec; 39(49):9852-9863. PubMed ID: 31666356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
    Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
    Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model.
    Bilousova TV; Dansie L; Ngo M; Aye J; Charles JR; Ethell DW; Ethell IM
    J Med Genet; 2009 Feb; 46(2):94-102. PubMed ID: 18835858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sound-driven cortical phase-locking change in the Fmr1 KO mouse requires Fmr1 deletion in a subpopulation of brainstem neurons.
    Holley AJ; Shedd A; Boggs A; Lovelace J; Erickson C; Gross C; Jankovic M; Razak K; Huber K; Gibson JR
    Neurobiol Dis; 2022 Aug; 170():105767. PubMed ID: 35588990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reelin central fragment supplementation improves cognitive deficits in a mouse model of Fragile X Syndrome.
    Morrill NK; Joly-Amado A; Li Q; Prabhudeva S; Weeber EJ; Nash KR
    Exp Neurol; 2022 Nov; 357():114170. PubMed ID: 35863501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome.
    Su T; Fan HX; Jiang T; Sun WW; Den WY; Gao MM; Chen SQ; Zhao QH; Yi YH
    Psychopharmacology (Berl); 2011 May; 215(2):291-300. PubMed ID: 21181121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
    Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L
    Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.